The U.S. remote therapeutic monitoring market size was estimated at USD 386.89 million in 2024 and is projected to grow at a CAGR of 17.2% from 2025 to 2030. The rising prevalence of musculoskeletal disorders, technological advancements in wearables and mobile health devices, and growing preference for telemedicine and telehealth solutions are factors contributing to market growth. In addition, artificial intelligence (AI) supported remote therapeutic monitoring (RTM) platforms enable more accurate, efficient, and personalized monitoring of patients' therapeutic progress by leveraging advanced data analytics, machine learning, and real-time feedback.
The development of advanced wearable devices, sensors, and connected health tools has significantly contributed to the growth of the remote therapeutic monitoring (RTM) market. Modern wearables and sensors can accurately track various health parameters, including heart rate, blood pressure, glucose levels, and respiratory function. These devices are becoming increasingly affordable, user-friendly, and precise, making them ideal for remote monitoring. In addition, the integration of these devices with mobile apps and cloud-based platforms facilitates seamless data collection, real-time monitoring, and effective communication between healthcare providers and patients.
Remote therapeutic monitoring (RTM) plays a crucial role in reducing the need for frequent in-person visits, hospital readmissions, and emergency care, ultimately leading to significant cost savings for healthcare providers and insurance companies. By enabling continuous patient monitoring, RTM allows healthcare providers to intervene at an early stage, helping to mitigate health issues and reduce the reliance on expensive treatments.
A key industry trend is the integration of RTM solutions with electronic health records (EHR) and electronic medical records (EMR). This integration enables healthcare providers to access real-time patient data, facilitating more accurate diagnoses and personalized treatment plans. For instance, Adhere+, an all-in-one RTM solution developed by Adhere+ Corporation, is specifically designed to integrate seamlessly with EHR and EMR systems, enhancing clinical workflows and improving patient care outcomes.
Furthermore, the widespread adoption of telemedicine and virtual healthcare services, particularly accelerated by the COVID-19 pandemic, has created a conducive environment for expanding remote therapeutic monitoring (RTM). With many healthcare providers now incorporating remote consultations into their practice, RTM systems are poised to enhance telemedicine by delivering real-time patient data to support these virtual interactions. This integration enables healthcare professionals to make more informed decisions regarding treatment and interventions based on continuously monitored health metrics. As telemedicine continues to evolve, RTM is expected to play a pivotal role in the future of virtual healthcare delivery.
The case study from OneStep highlights the use of RTM solutions in monitoring and treating patients with precision using ongoing and objective mobility insights.
Business Challenges: Synergy Care, a U.S.-based contract therapy services provider, faced challenges with payer refusals, staff training, and designing workflows to implement remote monitoring.
The company implemented OneStep’s digital care workflows and RTM programs to reimburse bills related to all 4 CPT codes for the musculoskeletal system, ensuring ROI from RTM within 60 days.
Synergy Care adopted the OneStep RTM solution and successfully reimbursed all 4 CPT codes for the musculoskeletal system, enhancing their revenue while improving patient outcomes. In addition, this platform helped Synergy Care clinicians and patients enhance clinical outcomes using ongoing and objective mobility insights.
“Adopting OneStep has been a real clinical breakthrough for us. The insights we now get help us identify fall risks sooner and provide more tailored care - while generating a new revenue source.”
-Aaron Duffee, COTA/L, Regional Manager, Synergy Care
The chart below illustrates the relationship between industry concentration, industry characteristics, and industry participants. The x-axis represents the level of industry concentration, ranging from low to high. The y-axis represents various industry characteristics, including industry competition, level of partnerships & collaboration activities, degree of innovation, impact of regulations, and regional expansion. The U.S. remote therapeutic management (RTM) market is highly fragmented, with the presence of several RTM platform & solution providers dominating the market. The degree of innovation is high, and the level of merger & acquisition activities is moderate. The impact of regulations on industry is high and the product expansion of the industry is moderate.
The U.S. Remote Therapeutic Monitoring (RTM) Market experiences a high degree of innovation driven by technological advancements. Integrating artificial intelligence into these systems allows for more informed decision-making regarding treatment adjustments and interventions. For instance, In November 2024, Academy Medtech Ventures launched Move PT, an AI-powered digital health platform aimed at improving rehabilitation care and patient outcomes. Utilizing advanced AI, RTM, and computer vision, Move PT provides physical therapists and healthcare providers with real-time data insights, enabling personalized exercise programs and enhancing decision-making for both in-person and remote care.
The industry is experiencing a moderate level of merger and acquisition activities undertaken by several key players. This is due to the desire to gain a competitive advantage in the industry, enhance technological capabilities, and consolidate in a rapidly growing market.
The regulatory landscape plays a critical role in shaping the Remote Therapeutic Monitoring (RTM) market by ensuring that devices and services meet safety, efficacy, and privacy standards. Compliance with medical device regulations, reimbursement policies, data security standards, and clinical validation requirements is essential for the widespread adoption of RTM technologies. In the U.S., the HIPAA sets standards for protecting patient data. The GDPR in the European Union also governs the collection and processing of personal data, including health information.
The industry is witnessing moderate product expansion, driven by an increasing customer base for remote therapeutic monitoring software and solutions. Firms are aligning with technology providers and consulting agencies to enhance their product offerings and expand market reach.
Based on deployment, the web & cloud-based segment held the largest market share of 73.65% in 2024 and is expected to register growth at the fastest CAGR from 2025 to 2030. Web and cloud-based deployments allow healthcare providers and patients to access monitoring tools from anywhere with an internet connection. Cloud computing facilitates real-time data collection and analysis, which is essential for effective remote therapeutic monitoring. By utilizing cloud platforms, healthcare providers gather patient data continuously from various connected devices such as wearables or mobile applications. The ability to analyze this data in real-time allows for immediate interventions when necessary, improving patient safety and quality of care.
Moreover, cloud-based platforms enable seamless sharing of patient data among different healthcare providers involved in a patient’s care journey. In addition, implementing web and cloud-based solutions often results in lower operational costs compared to traditional on-premises systems.
Therapeutic segment dominated the market in 2024 and accounted for the largest revenue share of 70.5%. One of the key advantages of collecting therapeutic data is its potential to enhance patient engagement. Therapeutic data enables real-time monitoring of patient progress. By continuously tracking how patients respond to treatments, healthcare providers are anticipated to make timely adjustments to therapy plans based on actual performance rather than relying solely on periodic office visits or assessments. This dynamic approach is expected to significantly enhance the effectiveness of treatment protocols by ensuring that interventions are tailored to meet individual patient needs promptly.
Furthermore, the non-physiological data segment is expected to grow at the fastest CAGR from 2025 to 2030. The non-physiological data allows healthcare professionals to monitor the physical aspects of a patient’s condition and the psychological and behavioral factors that influence health outcomes. The integration of non-physiological data into remote therapeutic monitoring supports comprehensive care models that prioritize holistic patient management. By considering both physiological and non-physiological factors, healthcare systems develop more robust strategies for managing chronic conditions, leading to enhanced quality of care and patient satisfaction.
The healthcare providers segment held the largest market share of 42.9% in 2024. Healthcare providers utilize RTM tools to enhance patient care by continuously monitoring patients’ health conditions. This is beneficial for managing chronic diseases such as diabetes, hypertension, and heart diseases. Moreover, RTM facilitates better communication between patients and healthcare providers. Through remote monitoring systems, providers engage with patients more frequently without requiring them to visit a clinic. In addition, the integration of RTM into clinical practice allows healthcare providers to leverage data analytics for informed decision-making. With access to comprehensive health data collected remotely, clinicians are anticipated to identify trends and patterns that may indicate worsening conditions or treatment efficacy, enabling personalized treatment plans.
The patients & caregivers segment is anticipated to grow at the fastest CAGR from 2025 to 2030. Similarly, the payers segment is anticipated to grow significantly during the forecast period. The implementation of RTM allows players to manage healthcare costs more efficiently. Payers are anticipated to influence the adoption of RTM by offering flexible reimbursement policies. By allowing providers to bill for remote monitoring services at rates similar to those for in-person visits, payers incentivize the integration of these technologies into routine care. This financial support encourages providers to utilize RTM solutions more effectively.
U.S. Remote Therapeutic Monitoring Market in the U.S. is experiencing significant growth, advanced healthcare infrastructure and technological advancements. Moreover, increasing adoption of telemedicine and telehealth solutions contributes to market growth. For instance, in July 2023, ATI Physical Therapy formed a strategic partnership with Genie Health to create a hybrid-care model that combines virtual physical therapy with in-person care across over 900 clinics in 24 states.
Key players operating in the U.S. Remote Therapeutic Monitoring (RTM) Market are undertaking various initiatives to strengthen their market presence and increase the reach of their products and services. Strategies such as new product launches and partnerships are playing a key role in propelling the market growth.
In February 2025, Fyzical Therapy Balance Centers partnered with Sara Health to enhance patient care through remote therapeutic monitoring. The initiative focuses on improving outcomes for patients with balance and mobility issues through innovative technology.
“SaRA Health's platform significantly enhances patient care by allowing for seamless remote monitoring and communication,”
-Scott Gardner, a three-unit FYZICAL Franchise owner and Franchise Advisory Council President.
“Patients appreciate the ease through which they can interact with their therapists, which in turn fosters better adherence to treatment plans. Therapists benefit from integrating SaRA Health into their workflow, enabling more timely support. At the same time, practice owners see greater patient satisfaction, higher plan-of-care completion rates, and an additional source of revenue, which they in turn, can share with clinicians.”
In January 2025, Adhere+ launched Spanish-language integration for its remote therapeutic monitoring platform, enhancing healthcare equity and accessibility.
"This is a potentially transformational moment for my Spanish-speaking patients,"
-Dr. Gerald Ho, board-certified rheumatologist at the California-based Arthritis and Osteoporosis Medical Center.
"The Spanish-language integration on the Adhere+ platform allows me to extend RTM usage to my patients when English is not their first language. This allows them to engage with their care plans in a way that feels intuitive and empowering. It is a vital step that will help bridge critical gaps in communication, foster stronger patient-provider relationships, and help transform how we deliver care to diverse populations."
In November 2024, SoundHealth launched SONUCheck, an innovative feature in its SONU app. This feature enhances therapeutic monitoring by utilizing vocal analysis to assess nasal breathing.
In May 2024, MonitAir launched a comprehensive digital health platform that combines remote physiological monitoring, therapeutic oversight, chronic care management, and compliance tracking. This innovative solution supports healthcare providers overseeing patients with sleep apnea and chronic conditions through a single, streamlined interface.
In March 2022, Hero and Assure Health partnered to provide Remote Therapeutic Monitoring (RTM) using Hero's medication management solution for eligible Medicare enrollees. This collaboration aims to enhance healthcare for seniors by virtually monitoring patients and improving medication adherence.
Report Attribute |
Details |
Market size value in 2025 |
USD 439.3 million |
Revenue forecast in 2030 |
USD 969.8 million |
Growth rate |
CAGR of 17.2% from 2025 to 2030 |
Historical data |
2018 - 2024 |
Forecast period |
2025 - 2030 |
Quantitative units |
Revenue in USD million and CAGR from 2025 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Monitoring type, deployment mode, end-use |
Country scope |
U.S. |
Key companies profiled |
Zimmer Biomet; Medsien, Inc.; Adhere+ Corporation; Academy Medtech Ventures; CircleLink Health Inc.; Limber Health, Inc.; HealthArc; Hero Health, Inc.; Paindrainer AB; Physitrack; KangarooHealth; Spry Therapeutics Inc.; WebExercises; Blue Marble Health; MovementRX (Functional Dimensions LLC); HealthViewX; OneStep; IncludeHealth Inc,; Force; Propeller Health (Resmed) |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. remote therapeutic monitoring market report based on deployment mode, monitoring type, and end-use.
Deployment Mode Outlook (Revenue, USD Million, 2018 - 2030)
Cloud & Web based
On-premise
Monitoring Type Outlook (Revenue, USD Million, 2018 - 2030)
Therapeutic Data
Therapy Medication Adherence
Therapy Medication Response
Non-Physiological Data
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Healthcare Providers
Hospitals
Specialty Clinics
Rehabilitation Centers
Nursing Homes & Long-Term Care Facilities
Home Healthcare
Patients & Caregivers
Payers
b. The U.S. remote therapeutic monitoring market size was estimated at USD 386.89 million in 2024 and is expected to reach USD 439.35 million in 2025.
b. The U.S. remote therapeutic monitoring market is expected to grow at a compound annual growth rate of 17.16% from 2025 to 2030 to reach USD 969.81 million by 2030.
b. The web & cloud-based segment held the largest market share of 73.65% in 2024. Web and cloud-based deployments allow healthcare providers and patients to access monitoring tools from anywhere with an internet connection. Moreover, cloud-based platforms enable seamless sharing of patient data among different healthcare providers involved in a patient’s care journey.
b. Some key players operating in the U.S. RTM market include Zimmer Biomet; Medsien, Inc.; Adhere+ Corporation; Academy Medtech Ventures; CircleLink Health Inc.; Limber Health, Inc.; HealthArc; Hero Health, Inc.; Paindrainer AB; Physitrack; KangarooHealth; Spry Therapeutics Inc.; WebExercises; Blue Marble Health; MovementRX (Functional Dimensions LLC); HealthViewX; OneStep; IncludeHealth Inc,; Force; Propeller Health (Resmed).
b. Key factors driving the U.S. remote therapeutic monitoring market growth include technological advancements in wearables and mobile health devices, integration of artificial intelligence and machine learning in remote RTM platforms, and growing preference for telemedicine and telehealth solutions.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."